NCT04447716 2025-09-15An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to TreatmentThomas Jefferson UniversityPhase 1 Active not recruiting4 enrolled